Schonfeld Strategic Advisors LLC Adaptimmune Therapeutics PLC Transaction History

Schonfeld Strategic Advisors LLC

  • $13.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$3.5 - $5.68 $1.22 Million - $1.99 Million
-349,683 Closed
0 $0
Q3 2021

Nov 16, 2021
SELL
$3.44 - $6.37 $21,224 - $39,302
-6,170 Reduced 1.73%
349,683 $1.81 Million
Q2 2021

Aug 16, 2021
BUY
$3.86 - $5.78 $12,352 - $18,496
3,200 Added 0.91%
355,853 $1.52 Million
Q1 2021

May 17, 2021
BUY
$4.9 - $6.83 $1.73 Million - $2.41 Million
352,653 New
352,653 $1.87 Million

Others Institutions Holding ADAP

# of Institutions
82
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $96.4M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email